Filgrastim biosimilar - Bionaturis/CuraxysAlternative Names: BNT002 - Bionaturis
Latest Information Update: 22 Aug 2016
At a glance
- Originator Bionaturis
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants
- Mechanism of Action Granulocyte colony stimulating factor stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Lysosomal storage diseases; Neutropenia
Most Recent Events
- 22 Aug 2016 Discontinued for Neutropenia in Spain (unspecified route)
- 01 Jan 2015 No development reported for Neutropenia in Spain (unspecified route)